GlassScriptPhysician profile
Stephanie K Becker
NPI 1477630390
$63,305.93
in general payments reported to CMS, 2019-2025
34 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $7,872 · 2021: $1,199 · 2022: $12K · 2023: $7,329 · 2024: $1,668 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800 · Food and Beverage: $4,612 · Travel and Lodging: $629 · Education: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
| Food and Beverage | $4,611.54 |
| Travel and Lodging | $629.30 |
| Education | $225.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $22,126.90 | 2019 | |
| Sun Pharmaceutical Industries INC. | $16,512.57 | 2019-2025 | Cequa, Xelpros |
| Novartis Pharmaceuticals Corporation | $14,044.99 | 2019-2023 | |
| Vertical Pharmaceuticals, LLC | $1,813.98 | 2019 | |
| Abbvie INC. | $1,434.66 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Alcon Vision LLC | $1,295.63 | 2019-2025 | Simbrinza, Eysuvis, Clareon |
| Allergan, INC. | $925.74 | 2019-2022 | |
| Oyster Point Pharma, INC. | $446.65 | 2022-2025 | Tyrvaya |
| Dompe US, INC. | $445.93 | 2020-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $409.42 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Carl Zeiss Meditec, INC. | $400.00 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $371.78 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $347.10 | 2019-2024 | Omni Surgical System, Tearcare System |
| Merz North America, INC. | $289.07 | 2019 | |
| Kala Pharmaceuticals, INC. | $281.64 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $266.15 | 2020-2025 | Tecnis Iol, Amo Phaco Needle |
| Aerie Pharmaceuticals, INC. | $238.47 | 2019-2021 | |
| Rxsight INC | $210.44 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| New World Medical,INC. | $202.64 | 2020-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Eyevance Pharmaceuticals LLC | $195.55 | 2019-2023 | Flarex |
| Mallinckrodt Hospital Products INC. | $182.03 | 2023 | Acthar |
| Harrow Eye, LLC | $158.57 | 2024-2025 | Vevye |
| Osmotica Pharmaceutical Corp. | $147.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.39 | 2019-2021 | |
| Leadiant Biosciences, INC. | $133.58 | 2019-2025 | Cystaran |
| Ocular Therapeutix, INC. | $75.85 | 2021-2023 | Dextenza |
| Glaukos Corporation | $48.09 | 2019-2022 | |
| Biotissue Holdings INC. | $43.51 | 2024 | |
| Tearlab Corp | $34.30 | 2023 | Tearlab Osmolarity System |
| Carl Zeiss Meditec Cataract Technology INC. | $25.71 | 2019 | |
| Recordati_rare_diseases_inc. | $23.01 | 2023 | Cystadrops |
| Ivantis, INC | $17.98 | 2021 | |
| Rayner Intraocular Lenses Limited | $14.35 | 2022 | |
| Visioneering Technologies, INC. | $6.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.